StockData

Research Alliance Corp III (RACC) shareholders

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.12+0.00 (0.00%)

Close on Nov 17, 2026Market cap $92.08MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
81.7%
7M of 9M shares
Institutional holders
23
23 new, 0 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Matthew Hammond
Joint filing with Research Alliance Holdings III LLC (14.70%)
1,520,26914.70%13D (active)May 21, 2026
Research Alliance Holdings III LLC
Joint filing with Matthew Hammond (16.90%)
1,520,26916.90%13D (active) amendmentJul 26, 2026
Wilmot B. Harkey
Joint filing with Nantahala Capital Management, LLC (14.10%), Daniel Mack (14.10%)
1,100,00014.10%13G (passive)Sep 30, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (8.20%), Perceptive Life Sciences Master Fund, Ltd. (8.20%)
750,0008.20%13G (passive)May 20, 2026
Daniel Schneeberger
Joint filing with ADAR1 Capital Management, LLC (8.40%)
650,0008.40%13G (passive)Jun 30, 2026
Ms. Lillian Nordahl
Joint filing with Great Point Partners, LLC (6.49%), Dr. Jeffrey R. Jay, M.D. (6.49%)
504,8916.49%13G (passive)Sep 4, 2026
Bam Gp LLC
Joint filing with Balyasny Asset Management L.P. (6.43%), Balyasny Asset Management Holdings LP (6.43%) and 2 more
500,0006.43%13G (passive)Jun 30, 2026
Commodore Capital LP
Joint filing with Commodore Capital Master LP (5.50%), Robert Egen Atkinson (5.50%) and 1 more
500,0005.50%13G (passive)May 20, 2026
Simon Basseyn
Joint filing with Spruce Street Capital LP (6.40%), Alex R. Rosen (6.40%)
500,0006.40%13G (passive)Jun 30, 2026
TCG Crossover Fund III, L.P.
Joint filing with TCG Crossover GP III, LLC (6.40%), Chen Yu (6.40%)
500,0006.40%13G (passive)Jun 30, 2026
Trails Edge Biotechnology Master Fund, LP
Joint filing with Trails Edge Capital Partners, LP (5.50%), Ortav Yehudai (5.50%)
500,0005.50%13G (passive)May 21, 2026
Bvf Partners L P/Il
Joint filing with Bvf Inc/Il (6.40%), Lampert Mark N (6.40%) and 1 more
500,0006.40%13G (passive)May 21, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RACCValueChange% of portfolio
Perceptive Advisors LLC750,0008.24%$8.03MNew0.12%
ADAR1 Capital Management, LLC650,0007.14%$6.96MNew0.32%
TCG Crossover Management, LLC500,0005.50%$5.35MNew0.13%
Trails Edge Capital Partners, LP500,0005.50%$5.35MNew0.85%
Spruce Street Capital LP500,0005.50%$5.35MNew1.05%
Bvf Inc/Il500,0005.50%$5.35MNew0.14%
Balyasny Asset Management L.P.500,0005.50%$5.35MNew0.01%
Commodore Capital LP500,0005.50%$5.35MNew0.32%
Jupiter Topco LLC400,0004.40%$4.37MNew0.00%
Braidwell LP400,0004.40%$4.28MNew0.16%
Cormorant Asset Management, LP370,0004.07%$3.96MNew0.20%
Affinity Asset Advisors, LLC370,0004.07%$3.96MNew0.18%
Silverarc Capital Management, LLC360,0003.96%$3.85MNew0.40%
VR Adviser, LLC300,0003.30%$3.21MNew0.10%
Foresite Capital Management VI LLC300,0003.30%$3.21MNew0.50%
J. Goldman & Co LP177,5311.95%$1.90MNew0.05%
Toronto Dominion Bank146,8111.61%$1.57MNew0.00%
Logos Global Management LP100,0001.10%$1.07MNew0.05%
Aristeia Capital LLC50,0000.55%$535.00KNew0.01%
Two Sigma Investments, LP33,9120.37%$362.86KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026237M81.7%23 / 00 / 07M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Matthew HammondChief Executive Officer, Director, 10% owner275,0003.02%May 21, 2026
Henry William StusnickCOO and CBO––May 19, 2026
Francis Sherman AdamsChief Financial Officer––May 19, 2026
Alliance Holdings III LLC /Cayman ResearchDirector, 10% owner275,0003.02%May 21, 2026
Michael F. MacLeanDirector––May 19, 2026
Timothy J. MillerDirector––May 19, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Alliance Holdings III LLC /Cayman Research
Director, 10% owner
May 21, 2026Award+275,000$10.00$2.75M275,000
Matthew Hammond
Chief Executive Officer, Director, 10% owner
May 21, 2026Award+275,000$10.00$2.75M275,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.10%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-12.3%
From 0M shares
Short volume, 20 days
4.4%
Of volume reported to FINRA

Shares sold short, last 6 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Research Alliance Corp III's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,058 shares on Aug 25, 2026 over the last 90 days.

See a number that looks wrong?